Vimarsana
Biggest News Aggregation in the World

Page 6 - Psychedelic Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Psychedelic Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Psychedelic Studies Today - Breaking & Trending Today

Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates - Vimarsana News

Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates

Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.

Source: cbs12.com
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates - Vimarsana News

Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates

Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the

Source: 2news.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates - Vimarsana News

Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates

Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.

Source: fox17.com
Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates - Vimarsana News

Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates

Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.

Source: kimatv.com
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication - Vimarsana News

Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication

Federal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. Advisers to the Food and Drug Administration are scheduled to